Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports 
.

CONCLUSION: ECU successfully improved kidney function in a patient with GEM-HUS, while conventional treatment did not.
.
PMID: 27879189 [PubMed - as supplied by publisher]

Source: Clinical Nephrology - November 22, 2016 Category: Urology & Nephrology Authors: López Rubio ME, Rodado Martínez R, Illescas ML, Mateo Bosch E, Martínez Díaz M, de la Vara Inesta L, Cabezuelo B, Morales Albuja ME, Lucas Guillén E, Jimeno García L Tags: Clin Nephrol Source Type: research